XML 65 R41.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity (Details) (USD $)
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Share-based compensation      
Tax benefit from exercise of stock options and vesting of stock awards $ 2,038,000 $ 1,121,000 $ 2,917,000
Net adjustment to additional paid in capital related to excess tax benefits and deficiencies associated with share-based compensation awards 2,000,000 (1,400,000) 2,900,000
Gross tax deficiencies related to share-based compensation awards   1,100,000  
Gross tax benefits related to share-based compensation awards   2,500,000  
Stock options
     
Share-based compensation      
Vesting period (in years) 3 years    
Expiration period (in years) P10Y    
Stock option activity      
Outstanding, beginning of period (in shares) 3,775,586 5,185,091 4,668,490
Granted (in shares) 1,217,958 951,072 1,326,694
Forfeited (in shares) (86,986) (332,105) (732,846)
Exercised (in shares) (1,065,325) (2,028,472) (77,247)
Outstanding, end of period (in shares) 3,841,233 3,775,586 5,185,091
Vested and expected to vest end of period (in shares) 3,763,158    
Exercisable, end of period (in shares) 1,720,871    
Weighted average exercise price of stock options      
Outstanding, beginning of period (in dollars per share) $ 39.27 $ 38.19 $ 39.82
Granted (in dollars per share) $ 49.30 $ 42.70 $ 33.00
Forfeited (in dollars per share) $ 42.13 $ 40.66 $ 39.68
Exercised (in dollars per share) $ 38.34 $ 37.89 $ 33.38
Outstanding, end of period (in dollars per share) $ 42.65 $ 39.27 $ 38.19
Vested and expected to vest end of period (in dollars per share) $ 42.55    
Exercisable, end of period (in dollars per share) $ 40.02    
Weighted average remaining contractual term      
Outstanding, end of period (in years) 7.47    
Vested and expected to vest end of period (in years) 7.44    
Exercisable, end of period (in years) 6.03    
Aggregate intrinsic value      
Outstanding, end of the period 26,446,000    
Vested and expected to vest end of period 26,251,000    
Exercisable, end of period 16,268,000    
Closing stock price (in dollars per share) $ 49.47    
Total pre-tax intrinsic value of options exercised 13,100,000 18,200,000 400,000
Grants in period, weighted average grant date fair value (in dollars per share) $ 12.72 $ 11.74 $ 8.69
Estimates used for determining weighted average grant date fair value      
Risk-free interest rate (as a percent) 1.63% 1.74% 1.67%
Expected life (in years) 4 4 4
Expected volatility (as a percent) 29.88% 31.70% 30.20%
Expected dividend yield (as a percent) 0.00% 0.00% 0.00%
Unrecognized compensation expense 16,900,000    
Unrecognized compensation expense, period of recognition (in years) 1.89    
Aggregate fair value of options vested $ 10,300,000    
Nonvested restricted stock units
     
Share-based compensation      
Vesting period (in years) 3 years    
2011 Management Incentive Plan
     
Share-based compensation      
Maximum number of shares available 5,000,000    
Multiplier for delivery of shares under full-value awards 2.29    
Number of shares available for grant 4,886,385